ATLASAcumen Pharmaceuticals (ABOS) earnings date: expected January 23–29
Acumen Pharmaceuticals (ABOS) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 23–29. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ABOS
| Last price | $0.21 (-90.8%) |
|---|---|
| Normal 1-day range (±1σ) | ±10.4% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 6 reports |
These figures come from the same calibrated model and valuation as the Acumen Pharmaceuticals stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 23–29 (estimate). One email the day before, with ATLAS’s read on Acumen Pharmaceuticals. You can switch it off at any time.
Alert me before ABOS reportsFree to start. Creating an account takes under a minute.
ABOS earnings at a glance
| Next report | Not announced · expected around January 23–29 (ATLAS estimate) |
|---|---|
| Last report | Oct 26, 2026 · Beat |
| Beat rate (last 6 reports) | 5 of 6 (83%) |
| Average EPS surprise | +37.8% |
| Average move around a report | ±7.3% (last 6) |
| Sector | Healthcare · Biotechnology |
The expected window is an ATLAS estimate: it takes the typical gap between Acumen Pharmaceuticals’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Acumen Pharmaceuticals earnings history: last 6 reports
Acumen Pharmaceuticals last reported on Oct 26, 2026: EPS of -$0.35 against an estimate of -$0.43 (+18.6% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 26, 2026 | -$0.43 | -$0.35 | +18.6% | Beat | +14.1% |
| Aug 12, 2026 | -$0.41 | -$0.45 | -9.8% | Miss | +3.2% |
| May 12, 2026 | -$0.46 | -$0.33 | +28.3% | Beat | -3.1% |
| Mar 26, 2026 | -$0.56 | -$0.41 | +26.8% | Beat | -14.1% |
| Dec 17, 2025 | -$0.36 | $0.10 | +127.8% | Beat | +1.0% |
| Nov 12, 2025 | -$0.68 | -$0.44 | +35.3% | Beat | -8.1% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ABOS
See the fair value, the probability range and the earnings history of Acumen Pharmaceuticals on its ATLAS page.
Acumen Pharmaceuticals (ABOS) stock analysisPlans from €3.99 a month.
Acumen Pharmaceuticals earnings: frequently asked questions
When is Acumen Pharmaceuticals (ABOS) next earnings date?
Acumen Pharmaceuticals has not announced its next report. Its last 4 reports came Oct 26, 2026, Aug 12, 2026, May 12, 2026, Dec 17, 2025, so ATLAS estimates the next one around January 23–29. This is an estimate based on that pattern, not a confirmed date.
How often does ABOS beat earnings estimates?
Of its last 6 reports with a recorded result, Acumen Pharmaceuticals beat the EPS estimate 5 times; the average surprise was +37.8%. Past results do not predict the next one.
How much does ABOS move around earnings?
Over its last 6 reports the stock moved an average of 7.3% (absolute, from the close before the report day to the close after it), and finished higher 3 of 6 times.
Did Acumen Pharmaceuticals beat earnings estimates last quarter?
Acumen Pharmaceuticals last reported on Oct 26, 2026: EPS of -$0.35 against an estimate of -$0.43 (+18.6% surprise), a beat.
How much does ABOS usually move in a day?
On a normal trading day the ATLAS model puts ABOS’s one-day range at about ±10.4%, with a 47% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer